Treatment of Childhood Acute Lymphoblastic LeukemiaSTANULLA, Martin; SCHRAPPE, Martin.Seminars in hematology. 2009, Vol 46, Num 1, pp 52-63, issn 0037-1963, 12 p.Article

How I treat relapsed childhood acute lymphoblastic leukemiaLOCATELLI, Franco; SCHRAPPE, Martin; ESTER BERNARDO, Maria et al.Blood. 2012, Vol 120, Num 14, pp 2807-2816, issn 0006-4971, 10 p.Article

Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemiaLAUTEN, Melchior; CARIO, Gunnar; ASGEDOM, Girmay et al.Haematologica (Roma). 2003, Vol 88, Num 11, pp 1253-1258, issn 0390-6078, 6 p.Article

New treatment strategies in childhood acute lymphoblastic leukaemiaSCHRAPPE, Martin; BEIER, Rita; BÜRGER, Britta et al.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 4, pp 729-740, issn 1521-6926, 12 p.Article

Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemiaKRIEGER, David; MOERICKE, Anja; OSCHLIES, Ilske et al.Haematologica (Roma). 2010, Vol 95, Num 1, pp 158-162, issn 0390-6078, 5 p.Article

Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control studyKIDAS, Ekaterini; MÖRICKE, Anja; BEIER, Rita et al.International journal of hematology. 2009, Vol 89, Num 5, pp 584-591, issn 0925-5710, 8 p.Article

In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemiaWUCHTER, Christian; RUPPERT, Velia; SCHRAPPE, Martin et al.Blood. 2002, Vol 99, Num 11, pp 4109-4115, issn 0006-4971Article

Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trialsWILLER, Andrea; GERSS, Joachim; LANVERS-KAMINSKY, Claudia et al.Blood. 2011, Vol 118, Num 22, pp 5774-5782, issn 0006-4971, 9 p.Article

Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 StudyMANN, Georg; ATTARBASCHI, Andishe; SZCZEPANSKI, Tomasz et al.Blood. 2010, Vol 116, Num 15, pp 2644-2650, issn 0006-4971, 7 p.Article

Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90TALLEN, Gesche; RATEI, Richard; FENGLER, Ruediger et al.Journal of clinical oncology. 2010, Vol 28, Num 14, pp 2339-2347, issn 0732-183X, 9 p.Article

Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocolCARIO, Gunnar; ZIMMERMANN, Martin; DYER, Martin J. S et al.Blood. 2010, Vol 115, Num 26, pp 5393-5397, issn 0006-4971, 5 p.Article

Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhoodPRASAD, Rashmi B; HOSKING, Fay J; ROMAN, Eve et al.Blood. 2010, Vol 115, Num 9, pp 1765-1767, issn 0006-4971, 3 p.Article

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99) : an observational study and a multicentre randomised trial. CommentaryRIBERA, Josep-Maria; ORIOL, Albert; SZCZEPANSKI, Tomasz et al.Lancet (British edition). 2007, Vol 370, Num 9583, issn 0140-6736, 198-200, 240-250 [14 p.]Article

Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemiaSTANULLA, Martin; SCHAEFFELER, Elke; EICHELBAUM, Michel et al.JAMA, the journal of the American Medical Association. 2005, Vol 293, Num 12, pp 1485-1489, issn 0098-7484, 5 p.Article

Gene expression profiles and risk stratification in childhood acute lymphoblastic leukemiaTEUFFEL, Oliver; DETTLING, Marcel; CARIO, Gunnar et al.Haematologica (Roma). 2004, Vol 89, Num 7, pp 801-808, issn 0390-6078, 8 p.Article

Comparative genomic hybridization in childhood acute lymphoblastic leukemia : correlation with interphase cytogenetics and loss of heterozygosity analysisSCHOLZ, Inka; POPP, Susanne; FISCHER, Christine et al.Cancer genetics and cytogenetics. 2001, Vol 124, Num 2, pp 89-97, issn 0165-4608Article

Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002STARY, Jan; ZIMMERMANN, Martin; KONJA, Josip et al.Journal of clinical oncology. 2014, Vol 32, Num 3, pp 174-184, issn 0732-183X, 11 p.Article

Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk GroupECKERT, Cornelia; HENZE, Günter; SCHRAUDER, André et al.Journal of clinical oncology. 2013, Vol 31, Num 21, pp 2736-2742, issn 0732-183X, 7 p.Article

Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groupsATTARBASCHI, Andishe; MORAK, Maria; SCHWAB, Claire et al.British journal of haematology. 2012, Vol 158, Num 6, pp 772-777, issn 0007-1048, 6 p.Article

Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendationsGERR, Heidrun; ZIMMERMANN, Martin; SCHRAPPE, Martin et al.British journal of haematology. 2010, Vol 149, Num 1, pp 84-92, issn 0007-1048, 9 p.Article

Minimal Residual Disease Values Discriminate Between Low and High Relapse Risk in Children With B-Cell Precursor Acute Lymphoblastic Leukemia and an Intrachromosomal Amplification of Chromosome 21 : The Austrian and German Acute Lymphoblastic Leukemia Berlin-Frankfurt-Münster (ALL-BFM) TrialsATTARBASCHI, Andishe; MANN, Georg; MORICKE, Anja et al.Journal of clinical oncology. 2008, Vol 26, Num 18, pp 3046-3050, issn 0732-183X, 5 p.Article

Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemiaCLAVIEZ, Alexander; ECKERT, Cornelia; SEEGER, Karl et al.Haematologica (Roma). 2006, Vol 91, Num 2, pp 272-273, issn 0390-6078, 2 p.Article

Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia : Results from ALL-BFM 90 and 95SCHRAUDER, André; REITER, Alfred; LUDWIG, Wolf-Dieter et al.Journal of clinical oncology. 2006, Vol 24, Num 36, pp 5742-5749, issn 0732-183X, 8 p.Article

Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34⁺CD19^-cellsHOTFILDER, Marc; RÖTTGERS, Silja; ROSEMANN, Annegret et al.Cancer research (Baltimore). 2005, Vol 65, Num 4, pp 1442-1449, issn 0008-5472, 8 p.Article

PEG-asparaginase (Oncaspar) 2500 U/m² BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocolsMÜLLER, Hans-Joachim; BEIER, Rita; KRANZ, Karen et al.Cancer chemotherapy and pharmacology. 2002, Vol 49, Num 2, pp 149-154, issn 0344-5704Article